Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.46 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.46 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.46 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.45 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6229114 | 0.90 | ALDH1A1 (0.50) | KMT2AMEN1ALDH1A1ADRB2MAPK1 | |
| SCHEMBL6229108 | 0.90 | ALDH1A1 (0.50) | KMT2AMEN1ALDH1A1ADRB2MAPK1 | |
| SCHEMBL3248847 | 0.90 | KMT2A (0.47) | KMT2AMEN1ALDH1A1ADRB2LMNA | |
| SCHEMBL6231553 | 0.86 | KMT2A (0.48) | KMT2AMEN1ALDH1A1ADRB2MAPK1 | |
| SCHEMBL6230786 | 0.86 | KMT2A (0.48) | KMT2AMEN1ALDH1A1ADRB2MAPK1 | |
| SCHEMBL3253339 | 0.85 | CTSD (0.52) | KMT2AMEN1ALDH1A1ADRB2TSHR | |
| SCHEMBL3253330 | 0.85 | CTSD (0.52) | KMT2AMEN1ALDH1A1ADRB2TSHR | |
| SCHEMBL3256831 | 0.85 | CTSD (0.52) | KMT2AMEN1ALDH1A1ADRB2TSHR | |
| SCHEMBL6819827 | 0.85 | SMN1; SMN2 (0.54) | KMT2AMEN1ALDH1A1ADRB2LMNA | |
| SCHEMBL1549196 | 0.84 | ALDH1A1 (0.51) | ALDH1A1ADRB2TSHRSMN1; SMN2PLAAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1448514-B1 | NOVEL ALPHA-OXYGENATED CARBOXYLIC ACID PHENETHYLAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2010-05-19 | — | — | EP | disclosed |
| EP-1448514-B1 | NOVEL ALPHA-OXYGENATED CARBOXYLIC ACID PHENETHYLAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2010-05-19 | — | — | EP | disclosed |
| US-7700522-B2 | α-Oxygenated or α-thiolated carboxylic acid phenethylamide derivatives | SYNGENTA CROP PROTECTION, INC. (US) | 2010-04-20 | — | — | US | disclosed |
| US-7700522-B2 | α-Oxygenated or α-thiolated carboxylic acid phenethylamide derivatives | SYNGENTA CROP PROTECTION, INC. (US) | 2010-04-20 | — | — | US | disclosed |
| US-7700522-B2 | α-Oxygenated or α-thiolated carboxylic acid phenethylamide derivatives | SYNGENTA CROP PROTECTION, INC. (US) | 2010-04-20 | — | — | US | disclosed |
| US-20050038082-A1 | Novel $g(a)-oxygenated or $g(a)-thiolated carboxylic acid phenethylamide derivatives | SYNGENTA CROP PROTECTION, INC. | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038082-A1 | Novel $g(a)-oxygenated or $g(a)-thiolated carboxylic acid phenethylamide derivatives | CBR3, CBR1, GLRA1 | KMT2A 1404/4885MEN1 3952/4885ALDH1A1 482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.